Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry
Copyright © 2023. Published by Elsevier B.V..
Pompe disease is a rare genetic disorder with an estimated prevalence of 1:60.000. The two main phenotypes are Infantile Onset Pompe Disease (IOPD) and Late Onset Pompe Disease (LOPD). There is no published data from Spain regarding the existing number of cases, regional distribution, clinical features or, access and response to the treatment. We created a registry to collect all these data from patients with Pompe in Spain. Here, we report the data of the 122 patients registered including nine IOPD and 113 LOPD patients. There was a high variability in how the diagnosis was obtained and how the follow-up was performed among different centres. Seven IOPD patients were still alive being all treated with enzymatic replacement therapy (ERT) at last visit. Ninety four of the 113 LOPD patients had muscle weakness of which 81 were receiving ERT. We observed a progressive decline in the results of muscle function tests during follow-up. Overall, the Spanish Pompe Registry is a valuable resource for understanding the demographics, patient's journey and clinical characteristics of patients in Spain. Our data supports the development of agreed guidelines to ensure that the care provided to the patients is standardized across the country.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Neuromuscular disorders : NMD - 34(2024) vom: 13. Jan., Seite 1-8 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Acid maltase deficiency |
|---|
| Anmerkungen: |
Date Completed 24.01.2024 Date Revised 24.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.nmd.2023.10.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365784915 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365784915 | ||
| 003 | DE-627 | ||
| 005 | 20240124232019.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.nmd.2023.10.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1269.xml |
| 035 | |a (DE-627)NLM365784915 | ||
| 035 | |a (NLM)38087756 | ||
| 035 | |a (PII)S0960-8966(23)00746-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Martinez-Marin, Rafael Jenaro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.01.2024 | ||
| 500 | |a Date Revised 24.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023. Published by Elsevier B.V. | ||
| 520 | |a Pompe disease is a rare genetic disorder with an estimated prevalence of 1:60.000. The two main phenotypes are Infantile Onset Pompe Disease (IOPD) and Late Onset Pompe Disease (LOPD). There is no published data from Spain regarding the existing number of cases, regional distribution, clinical features or, access and response to the treatment. We created a registry to collect all these data from patients with Pompe in Spain. Here, we report the data of the 122 patients registered including nine IOPD and 113 LOPD patients. There was a high variability in how the diagnosis was obtained and how the follow-up was performed among different centres. Seven IOPD patients were still alive being all treated with enzymatic replacement therapy (ERT) at last visit. Ninety four of the 113 LOPD patients had muscle weakness of which 81 were receiving ERT. We observed a progressive decline in the results of muscle function tests during follow-up. Overall, the Spanish Pompe Registry is a valuable resource for understanding the demographics, patient's journey and clinical characteristics of patients in Spain. Our data supports the development of agreed guidelines to ensure that the care provided to the patients is standardized across the country | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Acid maltase deficiency | |
| 650 | 4 | |a Enzymatic replacement therapy | |
| 650 | 4 | |a Glycogen storage disease type II | |
| 650 | 4 | |a Myozime | |
| 650 | 4 | |a Patient registry | |
| 650 | 4 | |a Pompe disease | |
| 650 | 4 | |a Spanish Pompe registry | |
| 650 | 7 | |a alpha-Glucosidases |2 NLM | |
| 650 | 7 | |a EC 3.2.1.20 |2 NLM | |
| 700 | 1 | |a Reyes-Leiva, David |e verfasserin |4 aut | |
| 700 | 1 | |a Nascimento, Andrés |e verfasserin |4 aut | |
| 700 | 1 | |a Muelas, Nuria |e verfasserin |4 aut | |
| 700 | 1 | |a Dominguez-González, C |e verfasserin |4 aut | |
| 700 | 1 | |a Paradas, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Olivé, Montse |e verfasserin |4 aut | |
| 700 | 1 | |a García-Romero, Mar |e verfasserin |4 aut | |
| 700 | 1 | |a Pascual-Pascual, Samuel Ignacio |e verfasserin |4 aut | |
| 700 | 1 | |a Grau, Josep Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Barba-Romero, Miguel Angel |e verfasserin |4 aut | |
| 700 | 1 | |a Gomez-Caravaca, Maria Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a de Las Heras, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Casquero, Pilar |e verfasserin |4 aut | |
| 700 | 1 | |a Mendoza, Maria Dolores |e verfasserin |4 aut | |
| 700 | 1 | |a de León, Juan Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Gutierrez, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Morís, Germán |e verfasserin |4 aut | |
| 700 | 1 | |a Blanco-Lago, Raquel |e verfasserin |4 aut | |
| 700 | 1 | |a Ramos-Fransi, Alba |e verfasserin |4 aut | |
| 700 | 1 | |a Pintós, Guillem |e verfasserin |4 aut | |
| 700 | 1 | |a García-Antelo, Maria José |e verfasserin |4 aut | |
| 700 | 1 | |a Rabasa, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Morgado, Yolanda |e verfasserin |4 aut | |
| 700 | 1 | |a Usón, Mercedes |e verfasserin |4 aut | |
| 700 | 1 | |a Miralles, Francisco Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Bárcena-Llona, Jose Eulalio |e verfasserin |4 aut | |
| 700 | 1 | |a Gómez-Belda, Ana Belén |e verfasserin |4 aut | |
| 700 | 1 | |a Pedraza-Hueso, Maria Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Hortelano, Miryam |e verfasserin |4 aut | |
| 700 | 1 | |a Colomé, Antoni |e verfasserin |4 aut | |
| 700 | 1 | |a Garcia-Martin, Guillermina |e verfasserin |4 aut | |
| 700 | 1 | |a Lopez de Munain, Adolfo |e verfasserin |4 aut | |
| 700 | 1 | |a Jericó, Ivonne |e verfasserin |4 aut | |
| 700 | 1 | |a Galán-Dávila, Lucía |e verfasserin |4 aut | |
| 700 | 1 | |a Pardo, Julio |e verfasserin |4 aut | |
| 700 | 1 | |a Salgueiro-Origlia, Giorgina |e verfasserin |4 aut | |
| 700 | 1 | |a Alonso-Pérez, Jorge |e verfasserin |4 aut | |
| 700 | 1 | |a Pla-Junca, Francesc |e verfasserin |4 aut | |
| 700 | 1 | |a Schiava, Marianela |e verfasserin |4 aut | |
| 700 | 1 | |a Segovia-Simón, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Díaz-Manera, Jordi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuromuscular disorders : NMD |d 1993 |g 34(2024) vom: 13. Jan., Seite 1-8 |w (DE-627)NLM012649740 |x 1873-2364 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2024 |g day:13 |g month:01 |g pages:1-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nmd.2023.10.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2024 |b 13 |c 01 |h 1-8 | ||